GE Healthcare Technologies (GEHC) has been the subject of multiple investment activities from various firms, including Perpetual Ltd, Herbst Group LLC, and Salem Investment Counselors Inc. trading 459,112 shares, while Eagle Rock Investment Company LLC and Avity Investment Management Inc. have liquidated their positions. Despite some analyst sentiment leading to a lowered price target by Citi, GEHC remains a long-term value stock due to its continual advancement in medical technologies such as Photonova Spectra and Genesis Radiology Workspace, both of which have recently received FDA clearance. The value proposition of GEHC has been further strengthened after its spin-off from General Electric, and it's expected to yield growth in stock performance in the long-term despite recent price weaknesses. Despite recent lower profits, the revenue of GEHC is increasing, and the company is expanding offerings in healthcare technology. The company is also expected to capitalize on strong demand backlog.
Ge Healthcare Technologies GEHC News Analytics from Sat, 01 Nov 2025 07:00:00 GMT to Sat, 04 Apr 2026 23:40:13 GMT -
Rating 5
- Innovation 7
- Information 8
- Rumor -5
